Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
45.23
-0.20 (-0.44%)
At close: Sep 28, 2026, 4:00 PM EDT
46.57
+1.34 (2.96%)
Pre-market: Sep 29, 2026, 8:51 AM EDT
Veracyte Market Cap
Veracyte has a market cap or net worth of $3.64 billion as of September 28, 2026. Its market cap has increased by 38.21% in one year.
Market Cap
3.64B
Enterprise Value
3.19B
1-Year Change
38.21%
Ranking
Category
Stock Price
$45.23
ChartMarket Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $3.64B, an increase of 1,226.55%. That is a compound annual growth rate of 22.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 3.64B | 9.26% |
| Dec 31, 2025 | 3.33B | 8.44% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
| Oct 30, 2013 | 274.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qiagen | 9.14B |
| BillionToOne | 5.81B |
| GRAIL | 5.67B |
| RadNet | 5.57B |
| Sotera Health Company | 5.23B |
| Adaptive Biotechnologies | 4.70B |
| CareDx | 3.29B |
| GeneDx Holdings | 2.64B |